Akebia Therapeutics, Inc. trades on the Nasdaq stock exchange under the ticker symbol AKBA, with its live share price fluctuating continuously during active market trading hours. Recent trading data places the equity valuation below the two-dollar threshold—hovering around 0.90 USD per share. Because stock prices shift dynamically in response to quarterly earnings disclosures, macroeconomic factors, and investor sentiment, market participants should consult real-time financial tracking terminals or brokerage accounts to view the exact intraday quotation and trading volume.